Paul Lin
- Surgery top 5%
- Molecular Biology
- Genetics top 2%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Arnold I. CaplanJames E. DennisThomas J. KeanDiego CorreaWarren C. W. ChanSangeeta N. BhatiaStephen F. BadylakAmad Awadallah
- Topics
- Mesenchymal stem cell research (7 papers)Peptidase Inhibition and Analysis (5 papers)Multiple Myeloma Research and Treatments (3 papers)
- Cited by
- GeneticsGastroenterologyBiomaterials
- Journals
- BloodPLoS ONEHepatology
- Partner nations
- United StatesTaiwanJapan
In The Last Decade
Paul Lin
35 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 112
- Surgery 671
- Molecular Biology 545
- Genetics 498
- Oncology 376
- Pulmonary and Respiratory Medicine 296
Countries citing papers authored by Paul Lin
This map shows the geographic impact of Paul Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Lin more than expected).
Fields of papers citing papers by Paul Lin
This network shows the impact of papers produced by Paul Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Lin. The network helps show where Paul Lin may publish in the future.
Co-authorship network of co-authors of Paul Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Lin. A scholar is included among the top collaborators of Paul Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Lin. Paul Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 10 | |
| 4 | 26 | |
| 5 | 345 | |
| 6 | 24 | |
| 7 | 18 | |
| 8 | 45 | |
| 9 | 53 | |
| 10 | 149 | |
| 11 | 22 | |
| 12 | 11 | |
| 13 | 30 | |
| 14 | 36 | |
| 15 | 20 | |
| 16 | 151 | |
| 17 | 13 | |
| 18 | 56 | |
| 19 | 20 | |
| 20 | 42 |
About Paul Lin
Paul Lin is a scholar working on Genetics, Applied Microbiology and Biotechnology and Oncology, having authored 35 papers that have together received 1.8k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (7 papers), Peptidase Inhibition and Analysis (5 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Genetics (498 citations), Gastroenterology (167 citations) and Biomaterials (226 citations). Paul Lin has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include Arnold I. Caplan, James E. Dennis, Thomas J. Kean, Diego Correa, Warren C. W. Chan, Sangeeta N. Bhatia, Stephen F. Badylak, Amad Awadallah, Shui‐Yi Tung and Wen‐Cheng Chen. Their work appears in journals such as Blood, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.